Telefon:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antikoerper-online.de

Thrombomodulin Antikörper (THBD) Primary Antibody

THBD Reaktivität: Human FACS, WB Wirt: Ratte Monoclonal RTM98 unconjugated
Pubmed (3 Referenzen)
Produktnummer ABIN2192010
$659.59
Zzgl. Versandkosten $45.00
100 μg
Lieferung in 6 bis 8 Werktagen
  • Target Alle Thrombomodulin (THBD) Antikörper anzeigen
    Thrombomodulin (THBD)
    Reaktivität
    • 149
    • 34
    • 18
    • 5
    • 2
    Human
    Wirt
    • 92
    • 70
    • 5
    • 2
    • 1
    Ratte
    Klonalität
    • 87
    • 83
    Monoklonal
    Konjugat
    • 64
    • 22
    • 6
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Dieser Thrombomodulin Antikörper ist unkonjugiert
    Applikation
    • 84
    • 84
    • 63
    • 62
    • 38
    • 35
    • 34
    • 16
    • 15
    • 14
    • 13
    • 12
    • 9
    • 6
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Flow Cytometry (FACS), Western Blotting (WB)
    Sterilität
    0.2 μm filtered
    Klon
    RTM98
  • Applikationshinweise
    For flow cytometry and Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine optimal dilutions. The typical starting working dilution is 1:10.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS, containing 0.02 % sodium azide and 0.1 % bovine serum albumin.
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.
    Haltbarkeit
    12 months
  • Van de Wouwer, Conway: "Novel functions of thrombomodulin in inflammation." in: Critical care medicine, Vol. 32, Issue 5 Suppl, pp. S254-61, (2004) (PubMed).

    Dömötör, Benzakour, Griffin, Yule, Fukudome, Zlokovic: "Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1." in: Blood, Vol. 101, Issue 12, pp. 4797-801, (2003) (PubMed).

    Sturn, Kaneider, Feistritzer, Djanani, Fukudome, Wiedermann: "Expression and function of the endothelial protein C receptor in human neutrophils." in: Blood, Vol. 102, Issue 4, pp. 1499-505, (2003) (PubMed).

  • Target
    Thrombomodulin (THBD)
    Andere Bezeichnung
    Thrombomodulin, CD141 (THBD Produkte)
    Synonyme
    THBD, AHUS6, BDCA3, CD141, THPH12, THRM, TM, AI385582, thrombomodulin, THBD, Thbd
    Hintergrund
    Monoclonal antibody RTM96 recognizes thrombomodulin (a C-type lectin also known as CD141), a complex molecule located on the endothelium and a key feature in the protein C pathway. The protein C anticoagulant pathway serves as a major system for controlling coagulation and limiting inflammatory responses, and potentially decreasing endothelial cell apoptosis in response to inflammatory cytokines and ischemia. The essential components of the pathway involve thrombin, thrombomodulin, the endothelial cell protein C receptor (EPCR), protein C and protein S. Thrombomodulin binds thrombin, directly inhibiting its clotting and cell activation potential while at the same time augmenting protein C. The endothelial cell protein C receptor (EPCR) augments protein C activation by the thrombin-TM complex more than 10-fold. TM also accelerates thrombin activation of a plasma procarboxypeptidase B, named thrombin activatable fibrinolysis inhibitor or TAFI resulting in slowing clot lysis. The inhibited thrombin rapidly dissociates from thrombomodulin, regenerating the anticoagulant surface. Thrombomodulin also has direct anti- inflammatory activity, minimizing cytokine formation in the endothelium and decreasing leukocyte- endothelial cell adhesion. Thrombomodulin inhibits leukocyte binding to activated endothelium. TM has been detected in a variety of cells and tissues in adults and during development, including astrocytes in the brain, keratinocytes, endothelial cells, mesothelial cells of the peritoneum, and circulating neutrophils, monocytes, and platelets. During fetal development, TM plays a central role in controlling the growth and survival of trophoblast cells in the placenta, a function essential for the maintenance of pregnancy. Thrombin binding to thrombomodulin involves anion binding exosite 1 on thrombin and epidermal growth factor (EGF) domains 4 to 6 on thrombomodulin The monoclonal antibody RTM98 reacts with the EGF6 domain.
Sie sind hier:
Kundenservice